Ricerca avanzata

Attualmente, Jeremiah Alphonsus O'Callaghan è presidente di JBS SA e co-amministratore delegato di JBS Investments II GmbH e responsabile delle relazioni con gli investitori di JBS Foods International (entrambe controllate di JBS SA). Fa anche parte del consiglio di amministrazione di JBS Investments UK Ltd. Si è laureato presso lo University College Cork.

Attualmente, Jeremiah Brazeau è Chief Technology Officer di Twilio, Inc. In precedenza ha ricoperto la posizione di Senior Vice President & Distinguished Architect presso salesforce.com, inc. Ha conseguito una laurea e un diploma al Rochester Institute of Technology e una laurea alla Northeastern University.

Barbara S. Jeremiah è presidente designato di The Weir Group Plc. È anche membro dell'Università della Virginia e fa parte del consiglio di amministrazione di altre 6 società. In passato ha ricoperto la posizione di presidente di Boart Longyear Ltd., vicepresidente esecutivo di Alcoa Corp. e vicepresidente esecutivo dello sviluppo aziendale di Alcoa, Inc. Si è laureata alla Brown University e si è laureata alla University of Virginia School of Law.

Alphonsus Chia currently works at Digiassets Exchange (Singapore) Pte Ltd., as Chief Commercial & Partnership Officer.

Alphonsus Nicolaas Maria Koerhuis is currently the Director at Aviagen International Holdings Ltd.
and the Group CTO Research & Development at Aviagen Group Ltd.
He previously worked as the Chief Technology Officer at Aviagen Ltd.

Alphonsus Vrolix has worked as a Director at Rusthuizen ZA Noord-Limburg VZW since 2005.

Barry O’Callaghan currently works at Rise Global Holdings Ltd., as Chairman & Chief Executive Officer.
Mr. O’Callaghan also formerly worked at Houghton Mifflin Harcourt Publishing Co., as Chief Executive Officer, Riverdeep Interactive Learning Ltd., as Executive Chairman & Chief Executive Officer, Riverdeep Holdings Ltd., as Chief Executive Officer, Riverdeep, Inc., as Executive Chairman & Chief Executive Officer from 1999 to 2009, Education Media & Publishing Group Ltd., as Chairman & Chief Executive Officer, and Morgan Stanley, as Principal.
Mr. O’Callaghan received his graduate degree from Trinity College Dublin.

Mr. Shea O’Callaghan is a Research Associate at Mackie Research Capital Corp.

Michael O'Callaghan is an economist who currently works at The Economic & Social Research Institute.

Lawrence R.
O’Callaghan is currently a Director at Missouri Valley REIT, Inc. He was previously a Trustee at Sterling Real Estate Trust from 2003 to 2013.

Scott O'Callaghan is an Independent Director at North Mountain Merger Corp.
He previously worked as a Managing Director at MidOcean US Advisor LP from 2009 to 2010, and as an Independent Director at South Mountain Merger Corp.
from 2020 to 2021.
He also held Principal positions at Drexel Burnham Lambert Real Estate Associates II, Deutsche Bank Investment Management, Inc., and Bankers Trust & Co. Additionally, he was Head-Leveraged Sales at Bank of America Corp.
in 2009.
O'Callaghan received his undergraduate degree from Brown University in 1986.

Kevin O'Callaghan is currently the Co-Chairman & Chief Revenue Officer at Steer For Student Athletes, Inc. He previously worked as a Director at Saint Vincent's Catholic Medical Centers.

Jody O'Callaghan has worked as a Director of Operations & Real Estate at Holland & Hart LLP since 2003.

John F.
O’Callaghan is currently the EVP, Global Head-Field Marketing & Operations at Triton International Ltd.
Prior to this, he worked at Triton Container International Ltd.
for 22 years, where his last position was Senior VP-Europe & North America Subcontinent.
He obtained his undergraduate degree from Trinity College Dublin.

Patricia O'Callaghan is currently the Chief Executive Officer of Gold Coast Tourism Corp Ltd.
She is also a Director at Queensland Country Bank Ltd.
and Queensland Country Health Fund Ltd.

Michael O'Callaghan is currently a member of the Governors Board at the Business Council of British Columbia.

Brian O'Callaghan was the founder and had founded Biopartners GmbH in 2000, where he served as the President & Chief Executive Officer until 2004.
He is currently the Chief Executive Officer & Director at Deep Genomics, Inc. since 2023, Director at BIOCOM since 2013, Director at Century Club of San Diego, Independent Director at Bolt Biotherapeutics, Inc. since 2021, and Director at Petra Pharma Corp.
since 2017.
Mr. O'Callaghan has held former positions as the President, Chief Executive Officer & Director at Sangart, Inc. from 2008 to 2014, President, Chief Executive Officer & Director at Acucela, Inc. in 2013, Chief Executive Officer at Sonrgy, Inc. from 2015 to 2017, Chief Commercial Officer at NPS Pharmaceuticals, Inc. from 2007 to 2008, General Manager at Labcorp Drug Development, Inc., General Manager at Merck KGaA, GM-North American Transplantation & Immunology at Novartis Pharmaceuticals Corp.
from 2004 to 2006, and Chief Executive & Financial Officer at Kubota Pharmaceutical Holdings Co. Ltd.
Mr. O'Callaghan also served as a Director at Aquavit Pharmaceuticals, Inc., Intec Pharma Ltd., ObsEva SA from 2020 to 2023, and Decoy Biosystems, Inc., as well as an Independent Director at Indaptus Therapeutics, Inc. He holds an MBA from The HENLEY College.

Mr. Shannon O'Callaghan is an Analyst at UBS Securities LLC.
Mr. O'Callaghan was previously employed as a Managing Director by Nomura Securities International, Inc., an Analyst by Credit Agricole Securities (USA), Inc., Barclays Capital, Inc., and a Lehman Brothers, Inc. He received his undergraduate degree from Boston College, a graduate degree from Boston College and an MBA from Massachusetts Institute of Technology.

Mr. Conor O'Callaghan is a Managing Director at BTIG LLC.
Prior to BTIG, Mr. Conor was the Head of Investment Banking and a Managing Director within Structured Products at Brownstone Investment Group.
Previously, Mr. O’Callaghan was a Managing Director at Nomura Securities, where he held several senior roles in both the Investment Banking and Global Markets divisions throughout his decade with the firm.
Earlier in his career, he held similar roles at Barclays, Clay Finlay and Credit Suisse.